StockData
Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc. (RCKT) stock

RCKTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$2.11+0.00 (0.00%)

Close on Nov 18, 2026Market cap $231.62MP/E –Yield –

Rocket Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Rocket Pharmaceuticals's market cap was $271.66M on Nov 11, 2026, against $370.07M a year earlier. Over the last 5 years it ranged from $261.55M to $2.70B, with a median of $1.07B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$271.66M-28.5%
2025Dec 31, 2025$379.81M-66.8%
2024Dec 31, 2024$1.15B-57.6%
2023Dec 29, 2023$2.70B+103.5%
2022Dec 30, 2022$1.33B-5.6%
2021Dec 31, 2021$1.41B-53.5%
2020Dec 31, 2020$3.03B+185.3%
2019Dec 31, 2019$1.06B+79.7%
2018Dec 31, 2018$590.36M+730.9%
2017Dec 29, 2017$71.05M-56.7%
2016Dec 30, 2016$164.28M-45.1%
2015Dec 31, 2015$299.23M–

More Rocket Pharmaceuticals figures

See a number that looks wrong?